ReviewClinical pharmacology : advances and applications2021

Novel Approaches to Treating Relapsed and Refractory Multiple Myeloma with a Focus on Recent Approvals of Belantamab Mafodotin and Selinexor.

Nisha S Joseph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.